-
CF Trial Resumes Enrollment in Europe, Israel, to Test Eloxx’s ELX-02
Enrollment has resumed in Eloxx’s trial of ELX-02 for CF in Israel and Europe — but not in the U.S. — after being suspended amid the COVID-19 crisis. Click here to learn more.
What do you think of this news?
Log in to reply.